YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[Hands holding up columns of bar graph] We Are UBS Global Research has constructed a 56-stock basket of U.S. companies with higher forward growth, stronger cash-flow profitability and improving earnings momentum, arguing that valuations fo…
RESEARCH TRIANGLE PARK, N.C., October 07, 2026--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, tod…
RESEARCH TRIANGLE PARK, N.C., October 07, 2026--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, tod…
Q2 Earnings Roundup: UFP Technologies (NASDAQ:UFPT) And The Rest Of The Drug Development Inputs & Services Segment The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a l…
1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn't mean every stock is worth owning. Some companies face significant challenges, whether i…
Wall Street closed in the green on Friday after the September nonfarm payrolls report came in cooler than economists expected. The blue-chip Dow ended up 0.5%, the benchmark S&P 500 gained 0.7%, and the tech-focused Nasdaq Composite advanc…
IQVIA Holdings IQV reported second-quarter 2026 adjusted earnings of $3.15 per share, rising 12.1% year over year and beating the Zacks Consensus Estimate of $3.02 by 4.3%. Revenues of $4.37 billion increased 8.7% and topped the consensus…
Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST) Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today we…
RESEARCH TRIANGLE PARK, N.C., September 29, 2026--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and…
Company Logo The global pharmacovigilance software market is projected to grow from USD 4.5 billion in 2026 to USD 12.7 billion by 2036, at a 10.9% CAGR. Growth is driven by stricter drug safety regulations, expanding clinical trials, risi…
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fu…
IQVIA Holdings (IQV) has just priced a US$2b senior notes offering due 2034, a sizable refinancing move that reshapes its debt stack and gives investors fresh information on the company's funding costs and capital structure. Over the past…
IQVIA Holdings has delivered a strong share-price run recently, which naturally puts more focus on whether the cash it is expected to generate can support the current valuation. With the stock now trading in a different zone to where it sa…
IQVIA IQV stock has surged 60.1% in the past six months. The company's shares outpaced the industry's 4.1% return and the Zacks S&P 500 Composite's 14% rally. 6-Month Share Price PerformanceZacks Investment Research Image Source: Zacks Inv…
Broyhill Asset Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here. The Broyhill Equity Composite gained 8.8% in Q2, trailing the MSCI All Country World Index's 15.1% and…
Q2 Earnings Review: Drug Development Inputs & Services Stocks Led by Azenta (NASDAQ:AZTA) As the Q2 earnings season wraps, let's dig into this quarter's best and worst performers in the drug development inputs & services industry, includin…
It has been about a month since the last earnings report for NeuroPace, Inc. (NPCE). Shares have lost about 0.4% in that time frame, outperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release…
IQVIA sign on the building in Montreal, Quebec By JHVEPhoto Durham, North Carolina-based IQVIA Holdings Inc. (IQV) provides healthcare research services. Valued at $42.3 billion by market cap, the company offers analytics, technology solut…
IQVIA Holdings (IQV [https://seekingalpha.com/symbol/IQV]) announced on Wednesday that its wholly owned subsidiary, IQVIA, priced an offering of $2B in aggregate principal amount of senior notes due 2034. The proceeds from the notes offeri…
RESEARCH TRIANGLE PARK, N.C., September 09, 2026--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the "Issuer"), priced an offering of $2,000,000,000 in aggregate prin…
RESEARCH TRIANGLE PARK, N.C., September 09, 2026--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the "Issuer"), intends to raise $2,000,000,000 through an offering of…
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fu…
IQVIA (IQV): Buy, Sell, or Hold Post Q2 Earnings? The past six months have been a windfall for IQVIA's shareholders. The company's stock price has jumped 50%, hitting $267.77 per share. This was partly thanks to its solid quarterly results…
1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it will…
RESEARCH TRIANGLE PARK, N.C., September 03, 2026--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Develo…
Veeva Systems Inc. VEEV raised its fiscal 2027 outlook after second-quarter revenues increased 17.6% year over year to $928 million. Vault CRM adoption and broader commercial execution added another positive signal. The question is how qui…
A month has gone by since the last earnings report for TransMedics (TMDX). Shares have added about 10.2% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent positive trend continue leading up…
Quick Read PAYC retired 20% of its shares for $1.4 billion near 52-week lows, and the stock has nearly doubled since April. Paycom drew $900 million from its credit line to fund the buyback while raising full-year adjusted EBITDA guidance…
Photo by manseok_Kim on Pixabay The market is obsessed with a handful of hyperscalers, but the real story might be the thousands of customers you've never heard of. You've seen the run in NVIDIA (NVDA) stock. You know the story about the a…
Q2 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment As the Q2 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the drug development in…
Earlier in the current quarter, IQVIA Holdings reported second-quarter results that topped earnings expectations, with adjusted earnings rising 12.1% year over year and revenue increasing 8.7%, prompting management to raise its 2026 revenu…
RESEARCH TRIANGLE PARK, N.C., August 27, 2026--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, toda…
It has been about a month since the last earnings report for IQVIA Holdings (IQV). Shares have added about 5.6% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release,…
Shares of IQVIA IQV have had an excellent run over the past month. The stock has gained 21.7% compared with the industry and the Zacks S&P 500 Composite's growth of 9.7% and 3.5%, respectively. The company's third-quarter 2026 earnings are…
2 Large-Cap Stocks with Exciting Potential and 1 That Underwhelm Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is…
Veeva Systems VEEV is scheduled to report second-quarter fiscal 2027 results on Aug. 26, after the market close. In the last reported quarter, the company's earnings per share (EPS) of $2.24 topped the Zacks Consensus Estimate by 5.16%. Ov…